News
Sanofi and Regeneron should hear from the FDA in the autumn whether it will approve their blockbuster immunology drug Dupixent as a therapy for rare skin disease prurigo nodularis (PN).
Atopic dermatitis is a chronic disease that disproportionately impacts communities of color Dupixent achieved ...
Residential houses are seen destroyed after a Russian drone strike in Pryluky village, Ukraine, Thursday, June 5, 2025.
Older adults with cardiovascular disease (CVD) or CVD risk factors report that gaps in communication among their providers are common and hazardous.
6d
Verywell Health on MSN10 Tips to Help Manage Migraine Brain FogMigraine brain fog is confusion, language and memory problems, and difficulty concentrating following an attack. Learn 10 ways to manage this issue.
Galderma (SIX: GALD) today announced two-year data from a new interim analysis of a long-term extension study investigating the saf ...
The latest update atopic dermatitis guidelines include the new approval of lebrikizumab and the expanded use of baricitinib and abrocitinib.
New interim two-year data from a long-term extension study of Nemluvioin atopic dermatitis reinforce its rapid onset of action and demonstrate its ...
5d
Dropbox on MSNUnexpected Visitors in Georgia’s Backyards 🦊🕸️Georgia’s backyards are teeming with a diverse array of wildlife, from common critters to unexpected guests. In this video, ...
Specialty televisits remain common in the Veterans Health Administration following the COVID-19 pandemic, suggesting they will remain an important ongoing care modality for many patients.
prurigo nodularis, CSU, and chronic obstructive pulmonary disease. Servier’s ASCO 2025 Data: Advancing IDH-Mutated Cancer Treat... At ASCO 2025, Servier’s Becky Martin discusses IDH-mutated ...
Improves fibrosis and steatohepatitis Metabolic dysfunction-associated steatotic liver disease (MASLD) encompasses a broad clinical spectrum, ranging from simple steatosis to metabolic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results